Src controls castration recurrence of CWR22 prostate cancer xenografts

Oncogene-specific activation of tyrosine kinase networks during prostate cancer progression

(2012) J. M. Drake et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Metastatic Progression of Prostate Cancer and E-Cadherin

(2011) Aaron P. Putzke et al.   AMERICAN JOURNAL OF PATHOLOGY

Dasatinib combined with docetaxel for castration-resistant prostate cancer

(2011) John C. Araujo et al.   CANCER

Novel Molecular Targets for the Therapy of Castration-Resistant Prostate Cancer

(2011) Neeraj Agarwal et al.   EUROPEAN UROLOGY

Small-molecule protein tyrosine kinase inhibitors for the treatment of metastatic prostate cancer

(2011) Gary E Gallick et al.   Future Medicinal Chemistry

Ligand-dependent Corepressor Acts as a Novel Androgen Receptor Corepressor, Inhibits Prostate Cancer Growth, and Is Functionally Inactivated by the Src Protein Kinase

(2011) Mohammad Asim et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Androgen Receptor Rediscovered: The New Biology and Targeting the Androgen Receptor Therapeutically

(2011) Charles J. Ryan et al.   JOURNAL OF CLINICAL ONCOLOGY

Minireview: Alternative Activation Pathways for the Androgen Receptor in Prostate Cancer

(2011) Kristin R. Lamont et al.   MOLECULAR ENDOCRINOLOGY

Correction: Bone metastasis in prostate cancer: emerging therapeutic strategies

(2011) Justin Sturge et al.   Nature Reviews Clinical Oncology

Emerging treatment options for patients with castration-resistant prostate cancer

(2011) Daniel George et al.   PROSTATE

Invasive Prostate Carcinoma Driven by c-Src and Androgen Receptor Synergy

(2010) H. Cai et al.   CANCER RESEARCH

The Neuroendocrine-Derived Peptide Parathyroid Hormone-Related Protein Promotes Prostate Cancer Cell Growth by Stabilizing the Androgen Receptor

(2009) J. DaSilva et al.   CANCER RESEARCH

Phase II Study of Dasatinib in Patients with Metastatic Castration-Resistant Prostate Cancer

(2009) E. Y. Yu et al.   CLINICAL CANCER RESEARCH

Src Family Kinase Activity Is Up-Regulated in Hormone-Refractory Prostate Cancer

(2009) O. Tatarov et al.   CLINICAL CANCER RESEARCH

Molecular mechanisms of castration-resistant prostate cancer progression

(2009) Smitha S Dutt et al.   Future Oncology

Src as a therapeutic target in men with prostate cancer and bone metastases

(2008) Fred Saad   BJU INTERNATIONAL

Targeting Src Family Kinases Inhibits Growth and Lymph Node Metastases of Prostate Cancer in an Orthotopic Nude Mouse Model

(2008) S. I. Park et al.   CANCER RESEARCH

Androgen-Regulated and Highly Tumorigenic Human Prostate Cancer Cell Line Established from a Transplantable Primary CWR22 Tumor

(2008) A. Dagvadorj et al.   CLINICAL CANCER RESEARCH

Expression of Src and FAK in Hepatocellular Carcinoma and the Effect of Src Inhibitors on Hepatocellular Carcinoma In Vitro

(2008) Grace M. Lau et al.   DIGESTIVE DISEASES AND SCIENCES

Bead-based profiling of tyrosine kinase phosphorylation identifies SRC as a potential target for glioblastoma therapy

(2008) Jinyan Du et al.   NATURE BIOTECHNOLOGY

Src kinase potentiates androgen receptor transactivation function and invasion of androgen-independent prostate cancer C4-2 cells

(2008) M Asim et al.   ONCOGENE

Inhibition of Hsp90 activates osteoclast c-Src signaling and promotes growth of prostate carcinoma cells in bone

(2008) A. Yano et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Oncogenic activation of androgen receptor

(2008) Hsing-Jien Kung et al.   UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS